Katrina Thornber, Author at European Medical Journal - Page 4 of 35

AI-Enhanced Ultrasound Scans Improve Efficiency and Reduce Sonographer Stress

AI can enhance the efficiency and accuracy of fetal anomaly ultrasound scans, reducing the workload on sonographers while maintaining high diagnostic performance.

ADHD Increases Dementia Risk due to Brain Iron and Axonal Damage

ADHD may increase risk of dementia due to elevated brain iron and neuroaxonal damage in adults.

Study Shows Mobile Health Intervention Feasible for Type 2 Diabetes Patients

A study has demonstrated the feasibility of a mobile health-supported home-delivered physical activity programme for individuals recently diagnosed with Type 2 diabetes.

Maternal Exposure to Polychlorinated Biphenyls Not Linked to Allergic Diseases

This study aimed to assess whether maternal exposure to LC-PCBs in indoor air during pregnancy was associated with the development of asthma.

Mini Rolling Robot Pioneers Virtual Biopsies for Early Cancer Detection

An oloid-shaped robot has enabled the use of 3D virtual biopsies, showing potential to transform early cancer detection in the gut.

The Role of LDL in Peripheral Artery Disease Depends on Remnant Cholesterol Levels

Genetic study with 796,722 participants reveals that remnant cholesterol drives PAD risk independently.

Neuroimaging Identifies Key Biomarkers of Friedreich Ataxia Progression in Childhood

The TRACK-FA study reveals that stalled spinal cord development in childhood Friedreich ataxia, offering new biomarkers for trials.

Broken Heart Syndrome: Machine Learning Identifies the Key Mortality Risks

Machine learning model predicts death risk in broken heart syndrome with 84% accuracy, a new study reveals.

Managing Catheter-Related Bladder Discomfort After Surgery

A randomised pilot study investigated whether scheduled IV acetaminophen administration would offer longer-lasting relief than a single dose.

Minimal Residual Disease May Predict NSCLC Recurrence After Osimertinib

Molecular residual disease detection may help identify patients with EGFR-mutated NSCLC who could benefit from prolonged adjuvant osimertinib